Cutera recently announced that it has received a medical device license from Health Canada for its Secret RF system.
“Canada is an important market for Cutera, and I am very happy that we are now able to introduce this innovative, skin revitalization technology to our Canadian customers,” Jason Richey, chief operating officer and interim CEO of Cutera, said in a press release. “Secret RF’s micro needling technique is a very popular treatment method in the U.S., and offers excellent clinical results, for physicians and their patients looking to improve and revitalize skin cancers. With this approval, we look forward to positively impacting revenue in this market.”
Secret RF is a fractional radiofrequency microneedling system for tissue coagulation. It is designed to stimulate and remodel collagen to reduce signs of aging.
“We’ve been partners with Cutera for several years, and have performed many clinical studies with their research team for advancing aesthetic technology,” Ashish Bhatia, a doctor at Oak Dermatology in Chicago, said. “With Secret RF, we’ve expanded our capabilities to provide patients individualized treatments, based on their skin concerns, skin type and lifestyle needs. With the adjustable levels of radio frequency and different tip sizes, we are able to go to different depths of delivering the right amount of energy to remodel the skin and generate collagen. Patient satisfaction is very high after only 1 or 2 treatments.”